The 15 advisors voted on Friday.

After a temporary moratorium on the use of the Johnson & Johnson COVID-19 vaccine, the CDC is now recommending resuming use.

The vaccine was originally on hold when reports surfaced of recipients developing rare blood clots after getting the shot. While the numbers originally added up to six people out of about 8 million Americans, that number is now up to 15, with three deaths, and the public has reacted strongly.

As it has only affected women up to this point, others used the news to highlight the risk of blood clots that hundreds of millions of women have to accept when they take birth control.

Whatever your feelings on the matter, the CDC's advisory committee "agreed the benefits of the vaccine outweigh the risks from rare blood clots linked with the vaccine," with the vote being "10 in favor, four opposed and one abstention." They stated, "The Janssen Covid-19 vaccine is recommended for persons 18 years of age and older in the U.S. population under the FDA’s emergency use authorization."

As a precaution, however, the label will be updated, "indicating that women under the age of 50 should be aware of the risk of blood clots from the vaccine."

You can read the full announcement from the FDA.

What are your thoughts? Does this change your mind about getting a vaccine? Let us know in the comments section below.